Oruka Therapeutics Stock (NASDAQ: ORKA) stock price, news, charts, stock research, profile.
You can purchase shares of Oruka Therapeutics (NASDAQ:ORKA) through any online brokerage.
Other companies in Oruka Therapeutics’s space includes: Upstream Bio (NASDAQ:UPB), Sage Therapeutics (NASDAQ:SAGE), aTyr Pharma (NASDAQ:ATYR), PureTech Health (NASDAQ:PRTC) and Monte Rosa Therapeutics (NASDAQ:GLUE).
Oruka Therapeutics has a consensus price target of $40.38.
The stock price for Oruka Therapeutics (NASDAQ: ORKA) is $10.7 last updated February 21, 2025 at 4:13 AM EST.
A quarterly cash dividend of 1.61 per share of Class A Common Stock. The quarterly cash dividend was payable on August 28, 2024 to stockholders of record on August 26, 2024.
Oruka Therapeutics’s Q1 earnings are confirmed for Thursday, May 15, 2025.
There is no upcoming split for Oruka Therapeutics.
Oruka Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.